# Orange County Bancorp, Inc.: overview OBT · Nasdaq · CIK 1754226 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/obt.md) · [Financials](/companies/obt/financials.md) · [Filings](/companies/obt/filings.md) · [Insiders](/companies/obt/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.28](/filings/0001104659-25-108979.md) | not reported | [0.77](/filings/0001104659-26-058511.md) | [0.87](/filings/0001104659-26-093345.md) | [0.75](/filings/0001104659-25-108979.md) | not reported | [0.85](/filings/0001104659-26-058511.md) | [1.02](/filings/0001104659-26-093345.md) | | Free cash flow | $m | [10.0 d](/filings/0001104659-25-108979.md) | [11.7 d](/filings/0001104659-26-028308.md) | [4.3](/filings/0001104659-26-058511.md) | [(5.7) d](/filings/0001104659-26-093345.md) | [29.6 d](/filings/0001104659-25-108979.md) | [13.1 d](/filings/0001104659-26-028308.md) | [9.7](/filings/0001104659-26-058511.md) | [12.3 d](/filings/0001104659-26-093345.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [4.28](/filings/0001558370-23-004543.md) | [4.33](/filings/0001558370-24-004354.md) | [2.62](/filings/0001558370-25-003120.md) | [2.47](/filings/0001104659-26-028308.md) | [3.33](/filings/0001104659-26-028308.md) | | Free cash flow | $m | [18.4](/filings/0001558370-23-004543.md) | [28.9](/filings/0001558370-24-004354.md) | [41.0](/filings/0001558370-25-003120.md) | [32.9](/filings/0001104659-26-028308.md) | [41.3](/filings/0001104659-26-028308.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/obt/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $72.1m | 1,960,135 | | Added +67,815 | | [Orange Investment Advisors, Inc.](/funds/943442.md) | 2026-06-30 | $39.0m | 1,060,922 | | Reduced −568 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $17.3m | 471,006 | | Added +9,304 | | [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $11.5m | 311,740 | | Added +76,460 | | [MANUFACTURERS LIFE INSURANCE COMPANY, THE](/funds/928047.md) | 2026-06-30 | $11.3m | 307,530 | | Reduced −1,780 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $10.7m | 290,181 | | Added +29,708 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $8.0m | 216,289 | | Added +29,141 | | [BANC FUNDS CO LLC](/funds/1029311.md) | 2026-06-30 | $6.8m | 186,035 | | Reduced −11,501 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $5.7m | 153,814 | | Added +26,878 | | [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $5.2m | 163,889 | | Reduced −55,310 | ## Recent filings [All 818 filings](/companies/obt/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-28 | 16:37 ET | [8-K](/filings/0000943374-26-000458.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000943374-26-000458 | | 2026-09-23 | 16:15 ET | [8-K](/filings/0001104659-26-109976.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-109976 | | 2026-08-21 | 16:30 ET | [8-K](/filings/0001104659-26-099710.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-099710 | | 2026-08-10 | 16:05 ET | [10-Q](/filings/0001104659-26-093345.md) | Quarterly report, period 2026-06-30 | 0001104659-26-093345 | | 2026-07-28 | 16:45 ET | [8-K](/filings/0000943374-26-000324.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000943374-26-000324 | | 2026-05-27 | 17:12 ET | [8-K](/filings/0000943374-26-000213.md) | 5.07 Shareholder vote results | 0000943374-26-000213 | | 2026-05-22 | 16:30 ET | [8-K](/filings/0001104659-26-065754.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-065754 | | 2026-05-11 | 13:12 ET | [10-Q](/filings/0001104659-26-058511.md) | Quarterly report, period 2026-03-31 | 0001104659-26-058511 | | 2026-04-28 | 17:02 ET | [8-K](/filings/0000943374-26-000176.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000943374-26-000176 | | 2026-04-15 | 16:01 ET | [DEF 14A](/filings/0001104659-26-043778.md) | Proxy statement, period 2026-05-26 | 0001104659-26-043778 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-028308.md), filed Mar 16, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1754226 - Tickers: OBT - Exchange: Nasdaq - SIC code: 6022 State Commercial Banks - State of incorporation: DE - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 14:29 ET. No prices; not investment advice.